Pfizer and its German partner BioNTech will seek emergency use authorization from the Food and Drug Administration for its COVID-19 candidate vaccine....
You are unauthorized to view this page. For access, please become a member.
The plan is to saturate the digital space with low-risk US artificial intelligence models, fast-track data center construction, and secure high-risk AI projects.